Stocksigma LogoStocksigma Logo

Genomic Valley Biotech Board Meeting on 30th Oct'26 for Q2 Earnings

Genomic Valley Biotech Limited has scheduled its Board of Directors meeting on 30th Oct'26 to consider and approve standalone unaudited financial results

Genomic Valley Biotech Board Meeting on 30th Oct'26 for Q2 Earnings

Genomic Valley Biotech Ltd 路 Intimation 路 30 Oct 2026, 5:30 am

Genomic Valley Biotech Board Meeting on 30th Oct'26 for Q2 Earnings Genomic Valley Biotech Limited has scheduled its Board of Directors meeting on 30th Oct'26 to consider and approve standalone unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed from 1st Oct'26 and will reopen 48 hours after the financial results are made public.

Original exchange filing (PDF)

More announcements from Genomic Valley Biotech Ltd

All Genomic Valley Biotech Ltd announcements